Andrew walks through Strainprint’s most recent patient, practitioner and industry data to answer the following questions:
- What are the top five symptoms and conditions that people are using medical cannabis to treat?
- What are the most effective methods of consumption and product types?
- What are the most common emotive effects (e.g. grogginess, sleepiness) being felt by medical cannabis users?
- What does all of this mean for the employer looking to support their employees in need of medical cannabis treatment?
About Andrew Muroff
Andrew Muroff, Chief Executive Officer, Strainprint Technologies, is a hands-on entrepreneur that has led public and private technology companies since 1995. To Strainprint, he brings deep corporate and financial experience, broad expertise across regulated cannabis markets in Canada and the U.S., and a passion to help people. He is a published legal author with graduate degrees in Business and Law and is a member of the State Bar of Michigan.